Does TECLISTAMAB-CQYV Cause Injection site rash? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Injection site rash have been filed in association with TECLISTAMAB-CQYV. This represents 0.9% of all adverse event reports for TECLISTAMAB-CQYV.
14
Reports of Injection site rash with TECLISTAMAB-CQYV
0.9%
of all TECLISTAMAB-CQYV reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site rash From TECLISTAMAB-CQYV?
Of the 14 reports, 3 (21.4%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Injection site rash Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Injection site rash?
ETANERCEPT (3,781)
DUPILUMAB (3,566)
ADALIMUMAB (2,108)
TIRZEPATIDE (1,131)
IXEKIZUMAB (526)
DULAGLUTIDE (501)
EVOLOCUMAB (465)
TERIPARATIDE (426)
SARILUMAB (424)
HYDROXYPROGESTERONE CAPROATE (384)
Which TECLISTAMAB-CQYV Alternatives Have Lower Injection site rash Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL